Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $16.3B | $16B | $15.8B | $4B | $3.8B | |
| Gross Profit | $7.6B | $7.6B | $7.6B | $1.9B | $1.8B | |
| Operating Income | $3.3B | $3.4B | $3.6B | $857M | $896.3M | |
| EBITDA | $4.6B | $4.7B | $4.9B | $1.2B | $1.2B | |
| Diluted EPS | $0.19 | $0.17 | $0.18 | $0.04 | $0.06 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $7B | $7.7B | $7.5B | $7.8B | $7.9B | |
| Total Assets | $25.7B | $26.9B | $28.1B | $27.6B | $27B | |
| Current Liabilities | $5.7B | $6.5B | $6.8B | $6.6B | $6.9B | |
| Total Liabilities | $9.5B | $9.9B | $9.8B | $9.4B | $9.6B | |
| Total Equity | $16.2B | $16.9B | $18.3B | $18.2B | $17.4B | |
| Total Debt | $497.8M | $533.1M | $495.9M | $591.8M | $512.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $4.4B | $5.1B | $4.6B | $1.5B | $1.3B | |
| Cash From Investing | -$913.3M | -$1.6B | -$777.9M | -$195.9M | -$215.9M | |
| Cash From Financing | -$3.3B | -$3.1B | -$3.8B | -$198.3M | -$634.4M | |
| Free Cash Flow | $3.3B | $4.1B | $3.8B | $1.3B | $1.1B | |
Ambev SA engages in the production, distribution, and sale of beverages. Its products include beer, carbonated soft drinks, and other non-alcoholic and non-carbonated products. It operates through the following geographical segments: Brazil, and Central America and The Caribbean (CAC), and Canada. The Brazil segment focuses on the beer sales division and the NAB sales division. The CAC segment includes its direct operations in the Dominican Republic, Saint Vincent, Antigua, Dominica, Cuba, Guatemala, Barbados, and Panama. The Canada segment covers includes domestic sales in Canada and some exports to the United States market. The Canada segment represents the Labatt’s operations. The company was founded in 1853 and is headquartered in São Paulo, Brazil.
In the current month, ABEV has received 1 Buy ratings 8 Hold ratings, and 1 Sell ratings. The ABEV average analyst price target in the past 3 months is $2.88.
According to analysts, the consensus estimate is that Ambev SA share price will rise to $2.88 per share over the next 12 months.
Analysts are divided on their view about Ambev SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ambev SA is a Sell and believe this share price will drop from its current level to $1.95.
The price target for Ambev SA over the next 1-year time period is forecast to be $2.88 according to 10 Wall Street analysts, 1 of them rates the stock a Buy, 1 rates the stock a Sell, and 8 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Ambev SA is a Hold. 8 of 10 analysts rate the stock a Hold at this time.
You can purchase shares of Ambev SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ambev SA shares.
Ambev SA was last trading at $2.37 per share. This represents the most recent stock quote for Ambev SA. Yesterday, Ambev SA closed at $2.37 per share.
In order to purchase Ambev SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.